158 related articles for article (PubMed ID: 32835206)
1. Virus inoculation and treatment regimens for evaluating anti-filovirus monoclonal antibody efficacy
Banadyga L; Schiffman Z; He S; Qiu X
Biosaf Health; 2019 Jun; 1(1):6-13. PubMed ID: 32835206
[TBL] [Abstract][Full Text] [Related]
2. Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein.
Keck ZY; Enterlein SG; Howell KA; Vu H; Shulenin S; Warfield KL; Froude JW; Araghi N; Douglas R; Biggins J; Lear-Rooney CM; Wirchnianski AS; Lau P; Wang Y; Herbert AS; Dye JM; Glass PJ; Holtsberg FW; Foung SK; Aman MJ
J Virol; 2016 Jan; 90(1):279-91. PubMed ID: 26468532
[TBL] [Abstract][Full Text] [Related]
3. Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses.
Holtsberg FW; Shulenin S; Vu H; Howell KA; Patel SJ; Gunn B; Karim M; Lai JR; Frei JC; Nyakatura EK; Zeitlin L; Douglas R; Fusco ML; Froude JW; Saphire EO; Herbert AS; Wirchnianski AS; Lear-Rooney CM; Alter G; Dye JM; Glass PJ; Warfield KL; Aman MJ
J Virol; 2016 Jan; 90(1):266-78. PubMed ID: 26468533
[TBL] [Abstract][Full Text] [Related]
4. Small Animal Models for Evaluating Filovirus Countermeasures.
Banadyga L; Wong G; Qiu X
ACS Infect Dis; 2018 May; 4(5):673-685. PubMed ID: 29457711
[TBL] [Abstract][Full Text] [Related]
5. Interaction between TIM-1 and NPC1 Is Important for Cellular Entry of Ebola Virus.
Kuroda M; Fujikura D; Nanbo A; Marzi A; Noyori O; Kajihara M; Maruyama J; Matsuno K; Miyamoto H; Yoshida R; Feldmann H; Takada A
J Virol; 2015 Jun; 89(12):6481-93. PubMed ID: 25855742
[TBL] [Abstract][Full Text] [Related]
6. Small animal models of filovirus disease: recent advances and future directions.
Cross RW; Fenton KA; Geisbert TW
Expert Opin Drug Discov; 2018 Nov; 13(11):1027-1040. PubMed ID: 30269599
[TBL] [Abstract][Full Text] [Related]
7. Chimeric Filoviruses for Identification and Characterization of Monoclonal Antibodies.
Ilinykh PA; Shen X; Flyak AI; Kuzmina N; Ksiazek TG; Crowe JE; Bukreyev A
J Virol; 2016 Apr; 90(8):3890-3901. PubMed ID: 26819310
[TBL] [Abstract][Full Text] [Related]
8. Animal models for filovirus infections.
Siragam V; Wong G; Qiu XG
Zool Res; 2018 Jan; 39(1):15-24. PubMed ID: 29511141
[TBL] [Abstract][Full Text] [Related]
9. Ferrets Infected with Bundibugyo Virus or Ebola Virus Recapitulate Important Aspects of Human Filovirus Disease.
Kozak R; He S; Kroeker A; de La Vega MA; Audet J; Wong G; Urfano C; Antonation K; Embury-Hyatt C; Kobinger GP; Qiu X
J Virol; 2016 Oct; 90(20):9209-23. PubMed ID: 27489269
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Human Monoclonal Antibody Monotherapy Against Bundibugyo Virus Infection in Nonhuman Primates.
Gilchuk P; Mire CE; Geisbert JB; Agans KN; Deer DJ; Cross RW; Slaughter JC; Flyak AI; Mani J; Pauly MH; Velasco J; Whaley KJ; Zeitlin L; Geisbert TW; Crowe JE
J Infect Dis; 2018 Nov; 218(suppl_5):S565-S573. PubMed ID: 29982718
[TBL] [Abstract][Full Text] [Related]
11. Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.
Warfield KL; Swenson DL; Olinger GG; Kalina WV; Aman MJ; Bavari S
J Infect Dis; 2007 Nov; 196 Suppl 2():S430-7. PubMed ID: 17940980
[TBL] [Abstract][Full Text] [Related]
12. Animal models for ebolavirus countermeasures discovery: what defines a useful model?
Shurtleff AC; Bavari S
Expert Opin Drug Discov; 2015 Jul; 10(7):685-702. PubMed ID: 26004783
[TBL] [Abstract][Full Text] [Related]
13. Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge.
Matassov D; Mire CE; Latham T; Geisbert JB; Xu R; Ota-Setlik A; Agans KN; Kobs DJ; Wendling MQS; Burnaugh A; Rudge TL; Sabourin CL; Egan MA; Clarke DK; Geisbert TW; Eldridge JH
J Virol; 2018 Feb; 92(3):. PubMed ID: 29142131
[TBL] [Abstract][Full Text] [Related]
14. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
15. Small Animal Models for Studying Filovirus Pathogenesis.
Yamaoka S; Banadyga L; Bray M; Ebihara H
Curr Top Microbiol Immunol; 2017; 411():195-227. PubMed ID: 28653189
[TBL] [Abstract][Full Text] [Related]
16. Filovirus contamination of cell cultures.
Peters CJ; Jahrling PB; Ksiazek TG; Johnson ED; Lupton HW
Dev Biol Stand; 1992; 76():267-74. PubMed ID: 1478345
[TBL] [Abstract][Full Text] [Related]
17. Post-exposure therapy of filovirus infections.
Wong G; Qiu X; Olinger GG; Kobinger GP
Trends Microbiol; 2014 Aug; 22(8):456-63. PubMed ID: 24794572
[TBL] [Abstract][Full Text] [Related]
18. A Single-Vector, Single-Injection Trivalent Filovirus Vaccine: Proof of Concept Study in Outbred Guinea Pigs.
Mire CE; Geisbert JB; Versteeg KM; Mamaeva N; Agans KN; Geisbert TW; Connor JH
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S384-8. PubMed ID: 25957964
[TBL] [Abstract][Full Text] [Related]
19. Testing Experimental Therapies in a Guinea Pig Model for Hemorrhagic Fever.
Wong G; Bi Y; Kobinger G; Gao GF; Qiu X
Methods Mol Biol; 2018; 1604():269-278. PubMed ID: 28986842
[TBL] [Abstract][Full Text] [Related]
20. Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections.
Swenson DL; Warfield KL; Negley DL; Schmaljohn A; Aman MJ; Bavari S
Vaccine; 2005 Apr; 23(23):3033-42. PubMed ID: 15811650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
